Roscommon-born MND patient Eoin Egan goes public as Neuralink GB-PRIME participant, demonstrating a thought-controlled wheelchair built with German assistive tech firm Homebrace
Eoin Egan, a 43-year-old Roscommon-born architect and property consultant living in London with motor neurone disease, has gone public as one of seven UK participants in Neuralink's GB-PRIME early feasibility study. Egan received his N1 Implant in December 2025 at UCLH's National Hospital for Neurology and Neurosurgery (Queen Square) in a six-hour robot-performed operation. Four days post-surgery he was driving his wheelchair through a London park with his thoughts alone, using bespoke software built by German assistive technology firm Homebrace that links the BCI cursor to wheelchair steering. He is the third UK GB-PRIME participant to surface publicly, after Paul (October 2025, also MND) and Sebastian Gomez (medical student paralysed in a diving accident).